The material selection platform
Cosmetics Ingredients
The material selection platform
Cosmetics Ingredients
Product News

INOLEX Receives Patent for Its Natural Multifunctional Preservation Technology

Published on 2021-02-03. Author : SpecialChem

TAGS:  Natural/ Organic   

INOLEX_Patents_PreservationINOLEX receives patent that claims multifunctional preservation systems comprising caprylhydroxamic acid (CHA) and select diols for cosmetics, personal care, and pharmaceuticals. The patent claims the use of these ingredient compositions in formulations as well as blends comprising the CHA-diol compositions.

CHA- Readily Biodegradable Chelating Agent

Caprylhydroxamic acid is a 100 percent natural and readily biodegradable chelating agent derived from coconut-sourced caprylic acid. CHA is a biostatic ingredient that provides a strong hurdle to microbial growth across a wide pH range (pH 4-8). Robust broad-spectrum protection against contamination by bacteria, yeast, and mold is achieved via combination of CHA with medium chain terminal diols, such as caprylyl glycol, glyceryl caprylate, or caprylyl glyceryl ether.

We have been advancing the industry with innovative preservation approaches for over two decades,” said David Plimpton, CEO and president of INOLEX. “This latest patent demonstrates our leadership in this category. Our broad portfolio of CHA offerings exemplifies our drive to bring effective alternative preservation mainstream.”

The company offers its portfolio of CHA-diol broad spectrum systems under the Spectrastat™ brand, with particular emphasis on 100% natural systems, such as Spectrastat™ G2 Natural MB (INCI: Caprylhydroxamic Acid (and) Glyceryl Caprylate (and) Glycerin).

Demonstrates Commitment for Safe Options

The patent granted recognizes INOLEX’s ongoing commitment to innovation in the field of safe, effective, and sustainable options for preservation of formulated products. In October 2020, the Cosmetic Ingredient Review (CIR) released its final report on the safety of caprylhydroxamic acid as used in cosmetics, in which the independent Expert Panel for Cosmetic Ingredient Safety concluded that CHA is safe as used in the present practices of the industry. This conclusion further validated the outstanding track record of safety associated with CHA.

As a company we have established high safety and transparency standards for all of our technologies. We proactively contributed our entire archive of safety and toxicological data on CHA for the benefit of our customers and their consumers. INOLEX also commissioned additional clinical safety studies and a quantitative risk assessment as requested by the Expert Panel to validate CHA safety at all use levels reported by CIR,” commented Dr. Michael Fevola, vice president of Research & Development at INOLEX.

Source: INOLEX
Channel Alerts

Receive weekly digests on hot topics

Back to Top